Works matching IS 00912700 AND DT 2008 AND VI 48 AND IP 12

Results: 10

Model-based development of a PPAR(gamma) agonist, rivoglitazone, to aid dose selection and optimize clinical trial designs.

Published in:

2008

By:

Rohatagi S;
Carrothers TJ;
Jin J;
Jusko WJ;
Khariton T;
Walker J;
Truitt K;
Salazar DE

Publication type:

Journal Article

Population Pharmacokinetic Analysis of Ibuprofen Enantiomers in Preterm Newborn Infants.

Published in:

Journal of Clinical Pharmacology, 2008, v. 48, n. 12, p. 1460, doi. 10.1177/0091270008323752

By:

Gregoire, Nicolas;
Desfrere, Luc;
Roze, Jean-Christophe;
Kibleur, Yves;
Koehne, Petra

Publication type:

Article

Pharmacokinetics and Safety of Ambrisentan in Combination With Sildenafil in Healthy Volunteers.

Published in:

Journal of Clinical Pharmacology, 2008, v. 48, n. 12, p. 1451, doi. 10.1177/0091270008324180

By:

Spence, Rebecca;
Mandagere, Arun;
Dufton, Christopher;
Venitz, Jürgen

Publication type:

Article

Effect of Dapoxetine on the Pharmacokinetics and Hemodynamic Effects of Tamsulosin in Men on a Stable Dose of Tamsulosin.

Published in:

Journal of Clinical Pharmacology, 2008, v. 48, n. 12, p. 1438, doi. 10.1177/0091270008324695

By:

Modi, N. B.;
Kell, S.;
Aquilina, J.;
Rivas, D.

Publication type:

Article

Bioequivalence Studies of Tibolone in Premenopausal Women and Effects on Expression of the Tibolone-Metabolizing Enzyme AKR1C (Aldo-Keto Reductase) Family Caused by Estradiol.

Published in:

Journal of Clinical Pharmacology, 2008, v. 48, n. 12, p. 1430, doi. 10.1177/0091270008323262

By:

Kang, Keon W.;
Kim, Yoon G.

Publication type:

Article

Model-Based Development of a PPARγ Agonist, Rivoglitazone, to Aid Dose Selection and Optimize Clinical Trial Designs.

Published in:

Journal of Clinical Pharmacology, 2008, v. 48, n. 12, p. 1420, doi. 10.1177/0091270008323260

By:

Rohatagi, Shashank;
Carrothers, Timothy J.;
JinYan Jin;
Jusko, William J.;
Khariton, Tatiana;
Walker, Joseph;
Truitt, Kenneth;
Salazar, Daniel E.

Publication type:

Article

Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment.

Published in:

Journal of Clinical Pharmacology, 2008, v. 48, n. 12, p. 1411, doi. 10.1177/0091270008324179

By:

Stangier, Joachim;
Stähle, Hildegard;
Rathgen, Karin;
Roth, Willy;
Shakeri-Nejad, Kasra

Publication type:

Article

Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Activator Cinaciguat (BAY 58-2667) in Healthy Male Volunteers.

Published in:

Journal of Clinical Pharmacology, 2008, v. 48, n. 12, p. 1400, doi. 10.1177/0091270008322906

By:

Frey, Reiner;
Mück, Wolfgang;
Unger, Sigrun;
Artmeier-Brandt, Ulrike;
Weimann, Gerrit;
Wensing, Georg

Publication type:

Article

Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus.

Published in:

Journal of Clinical Pharmacology, 2008, v. 48, n. 12, p. 1389, doi. 10.1177/0091270008323750

By:

Kothare, Prajakti A.;
Linnebjerg, Helle;
Isaka, Yoshitaka;
Uenaka, Kazunori;
Yamamura, Ayuko;
Kwee Poo Yeo;
de la Peña, Amparo;
Choo Hua Ten;
Mace, Kenneth;
Fineman, Mark;
Shigeta, Hirofumi;
Sakata, Yukikuni;
Irie, Shin

Publication type:

Article

Clinical Pharmacokinetics of XP13512, a Novel Transported Prodrug of Gabapentin.

Published in:

Journal of Clinical Pharmacology, 2008, v. 48, n. 12, p. 1378, doi. 10.1177/0091270008322909

By:

Cundy, Kenneth C.;
Sastry, Srikonda;
Wendy Luo;
Joan Zou;
Moors, Tristen L.;
Canafax, Daniel M.

Publication type:

Article